近年国内外均有孕激素受体在子宫肌瘤的发展中起协同作用的报告,现将米非司酮保守治疗子宫肌瘤51例疗效,报告如下。1资料与方法1·1临床资料:研究对象为2007年1月至12月在我院门诊,经盆腔B超检查证实为子宫肌瘤者51例,年龄35~55岁,平均(43±6)岁。子宫体积为妊娠40 d~3个月。其 In recent years, both at home and abroad have progesterone receptors in the development of uterine fibroids synergistic effect of the report, now the conservative treatment of uterine fibroids mifepristone efficacy of 51 cases, the report is as follows. 1 Materials and Methods 1.1 Clinical data: The study was performed in our hospital from January 2007 to December 2007, 51 cases of uterine fibroids confirmed by pelvic ultrasound B, aged 35 to 55 years, mean (43 ± 6 )year old. Uterine volume of pregnancy 40 d ~ 3 months. its